• Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer's Disease at the Clinical Trials in Alzheimer's Disease Conference

    8 days ago - By San Diego Biotechnology

    SAN CARLOS, Calif., Dec. 02, 2019 - Alkahest Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases, today announced an oral presentation of data fro......
    Read more ...